Suche

…Addiction Biology, DOI: 10.1111/adb.12383. Fattore, L. & Melis, M. (2016) Sex differences in impulsive and compulsive behaviors: a focus on drug addiction. Addiction Biology, DOI: 10.1111/adb.12381. Fattore…

Bereich: Topthema

…015 Kobayashi, N. H. C, Faria, S. V., Luz, D. A. et al. (2022). Ketamine plus Alcohol: What We Know and What We Can Expect about This. Int. J. Mol. Sci., 23(14), 7800. https://doi.org/10.3390/ijms23147800 [...] Curran, V. (2009). Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction, doi:10.1111/j.1360-0443.2009.02761 [...] & Curran, H. V. (2008) Journey through the K-hole: Phenomenological aspects of ketamine use. Drug and Alcohol Dependence, 95, 219-229. https://doi.org/10.1016/j.drugalcdep.2008.01.024 Palamar, J. J., …

Bereich: Topthema

…ogy, DOI : 10.2174/1570159X16666181108093520. Popkin, B. M., Adair, L. S. & Ng, S. W. (2012). NOW AND THEN: The Global Nutrition Transition: The Pandemic of Obesity in Developing Countries. Nutr Rev, 70(1) [...] addiction: the state of the science. Eur J Nutr, 55 (Supp 2), S55-S69. WHO (2018). Fact Sheets - Obesity and overweight. Wiss, D. A., Avena, N. &Rada, P. (2018). Sugar Addiction: From Evolution to Revolution…

Bereich: Topthema

… J. (2011). Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Canadian Journal of Public Health, 102 (5). 324-327. https://www.ncbi.nlm.nih.gov [...] Rehm, J. & Room, R. (2017). Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. American Journal of Public Health, 107 (8), e1-e12. https://doi.org/10.2105/AJPH.2017 [...] Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. International Journal of Drug Policy, 99, 103381. https://doi.org/10.1016/j…

Bereich: Topthema

…Kategorien zu fallen. Quellen: Auswärtiges Amt > Drogenbekämpfung Boivin, R. (2014). Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy. International…

Bereich: Topthema

…C., Gouzoulis-Mayfrank, E. & Daumann, J. (2012). Memory-related hippocampal functioning in ecstasy and amphetamine users. Psychopharmacology, 225 (4), 923-934. Fisk, J., Murphy, P. N., Montgomerys, C. & [...] Koester, P., Gouzoulis-Mayfrank, G. & Daumann, J. (2012). A prospective study of learning, memory, and executive function in new MDMA users. Addiction, 108 (1), 136-145. Was denkst du: Schädigt Ecstasy…

Bereich: Topthema

…T. et al. (2010). Evaluating the drug use “gateway” theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health…

Bereich: Topthema

…führt allerdings auch dazu, dass der Leidensdruck und die Motivation, das eigene Konsumverhalten zu ändern, bei dem Abhängigen abnehmen. Das Erklärungsmodell der Co-Abhängigkeit ist allerdings stark umstritten…

Bereich: Topthema

…V. (2015). Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom. Drug and Alcohol Dependence, 148, 165-171. Lemyre, A., Poliakova [...] L. M., Herrmann, E., Carpenter, M. J. & Peters, E. N. (2019). Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol, 27(3), 265-275. Weinberger [...] Poliakova, N. & Bélanger, R. E. (2018). The Relationship Between Tobacco and Cannabis Use: A Review. Substance Use & Misuse. 54(1), https://doi.org/10.1080/10826084.2018.1512623. McClure, E. A., Tomko, R…

Bereich: Topthema

…Hides, L. & Hall, W. D. (2020). What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis, Addictive Behaviors, doi: https://doi.org/10 [...] L. M., Herrmann, E., Carpenter, M. J. & Peters, E. N. (2019). Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol, 27(3), 265-275. Hast du…

Bereich: Topthema